EV/EBITDA
14.16
-0.06-0.42%
Thu, 13 Mar 2025 23:55:58 GMT
Summary
- As of March 14, 2025, REGN EV/EBITDA is 14.16, with a fall of -0.06 (-0.42%) during the most recent trading day.
- Over the past year, REGN EV/EBITDA has dropped by -8.59 (-37.76%).
- REGN EV/EBITDA is now -99.33% below its all-time high of 2125.69.
Performance
REGN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
REGN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.4% | -0.4% | -0.4% |
| 1 m1 month | +2.0% | +2.1% | +2.1% |
| 3 m3 months | -4.0% | -7.2% | -6.2% |
| 6 m6 months | -43.6% | -41.3% | -40.6% |
| ytdytd | -2.3% | -2.3% | -2.0% |
| 1 y1 year | -37.8% | -29.4% | -29.4% |
| 5 y5 years | -24.9% | +49.7% | +47.6% |
REGN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.3% | 13.88 | +2.0% | |
| 3 m | 3-month | 15.45 | -8.3% | 13.74 | +3.1% |
| 6 m | 6-month | 25.13 | -43.6% | 13.74 | +3.1% |
| 1 y | 1-year | 26.04 | -45.6% | 13.74 | +3.1% |
| 3 y | 3-year | 26.04 | -45.6% | 6.28 | +125.5% |
| 5 y | 5-year | 26.04 | -45.6% | 6.28 | +125.5% |
| alltime | all time | 2125.69 | -99.3% | -131.56 | +110.8% |
Regeneron Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 14.16(-2.3%) |
| 2024 | 14.49(-29.0%) |
| 2023 | 20.40(+36.3%) |
| 2022 | 14.97(+111.4%) |
| 2021 | 7.08(-44.3%) |
| 2020 | 12.71(-16.2%) |
| 2019 | 15.17(+3.6%) |
| 2018 | 14.64(-18.4%) |
| 2017 | 17.94(-33.4%) |
| 2016 | 26.95(-37.2%) |
| 2015 | 42.89(-12.7%) |
| 2014 | 49.14(+40.6%) |
| 2013 | 34.96(+2.9%) |
| 2012 | 33.97(-213.7%) |
| 2011 | -29.88(-24.2%) |
| 2010 | -39.43(+13.5%) |
| 2009 | -34.75(+65.9%) |
| Date | Value |
|---|---|
| 2008 | -20.95(+7.1%) |
| 2007 | -19.56(+42.8%) |
| 2006 | -13.70(-310.1%) |
| 2005 | 6.52(-77.9%) |
| 2004 | 29.48(-380.5%) |
| 2003 | -10.51(+26.3%) |
| 2002 | -8.32(-44.4%) |
| 2001 | -14.96(-60.9%) |
| 2000 | -38.23(+112.7%) |
| 1999 | -17.97(-19.9%) |
| 1998 | -22.44(-12.7%) |
| 1997 | -25.69(-25.9%) |
| 1996 | -34.66(-66.0%) |
| 1995 | -102.08(+5539.8%) |
| 1994 | -1.81(-77.1%) |
| 1993 | -7.89(-25.9%) |
| 1992 | -10.65(-77.0%) |
| 1991 | -46.37 |
FAQ
- What is Regeneron Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Regeneron Pharmaceuticals?
- What is REGN EV/EBITDA year-to-date change?
- What is Regeneron Pharmaceuticals EV/EBITDA year-on-year change?
What is Regeneron Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of REGN is 14.16
What is the all time high EV/EBITDA for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high EV/EBITDA is 2125.69
What is REGN EV/EBITDA year-to-date change?
Regeneron Pharmaceuticals EV/EBITDA has changed by -0.33 (-2.28%) since the beginning of the year
What is Regeneron Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, REGN EV/EBITDA has changed by -8.59 (-37.76%)